The USC Monoclonal Antibody Facility produces monoclonal and polyclonal antibodies for academic and clinical researchers within the State of South Carolina and throughout the nation.
Antibodies provide one of the mainstays of contemporary molecular and biological research.
The capacity of antibodies to recognize and bind to a wide range of types of molecules from peptides and carbohydrates to nucleic acids, and to identify specific antigenic determinants contained within these classes of molecules makes them extremely valuable in qualitative and quantitative analyses. The advent of hybridoma technology in recent years has made it possible to produce antibodies of restricted or unique specificity for use in a variety of techniques in cell biology and biochemistry. The technology involved in the production of monoclonal antibodies is straightforward, but time consuming. Dr. Loren Knapp, Director, Monoclonal Antibody Facility University of South Carolina 803 777-4606 .